AnodyneWiki

Pargyline

Pargyline
Pargyline
Salts
[]
Pargyline hydrochloride
Pargyline hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass159.23 g/mol [1]
Solubility9.98e-02 g/L [1]
Predicted LogP2.1 [1]
Structural Identifiers
[]
Molecular formulaC11H13N
IUPAC nameN-benzyl-N-methylprop-2-yn-1-amine
SMILESCN(CC#C)CC1=CC=CC=C1
InChIInChI=1S/C11H13N/c1-3-9-12(2)10-11-7-5-4-6-8-11/h1,4-8H,9-10H2,2H3
InChIKeyDPWPWRLQFGFJFI-UHFFFAOYSA-N
CAS number555-57-7
UNII9MV14S8G3E
PubChem CID4688
Pharmacokinetics[]
Routes of administrationOral[3]

Pargyline (also known as N-Methyl-N-propargylbenzylamine, Pargylamine, Eudatin, Paragyline, Supirdyl, N-Methyl-N-2-propynylbenzylamine, Pargilina, Pargylinum, Benzenemethanamine, N-methyl-N-2-propynyl- or benzyl(methyl)(prop-2-yn-1-yl)amine) is a monoamine oxidase inhibitor substance of the benzylamine class.

Chemistry

Salts []

Pargyline is typically found in the form of its hydrochloride salt.

 []

Pargyline is achiral.

Pargyline matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

MAOIs act by inhibiting the activity of monoamine oxidase, thus preventing the breakdown of monoamine neurotransmitters and thereby increasing their availability. There are two isoforms of monoamine oxidase, MAO-A and MAO-B. MAO-A preferentially deaminates serotonin, melatonin, epinephrine and norepinephrine. MAO-B preferentially deaminates phenylethylamine and trace amines. Pargyline functions by inhibiting the metabolism of catecholamines and tyramine within presynaptic nerve terminals. Catecholamines cause general physiological changes that prepare the body for physical activity (fight-or-flight response). Some typical effects are increases in heart rate, blood pressure, blood glucose levels, and a general reaction of the sympathetic nervous system. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

shared target3 (3 contraindicated)

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 4688, Pargyline. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4688
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Pargyline. UNII: 9MV14S8G3E. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/9MV14S8G3E
  3. Hayes AH, Schneck DW. Antihypertensive pharmacotherapy. Postgraduate Medicine. May 1976; 59(5):155–162. PMID 57611. https://doi.org/10.1080/00325481.1976.11714363

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 10:00:57
drugspromissing (no DrugsPRO reagent data)2026-11-20 10:00:53
erowidmissing (no Erowid substance of that name)2026-11-20 10:00:53
gsrsok2026-11-20 10:00:54
hmdbmissing (hmdb.ca refused automated access to HMDB0015563)2026-11-20 10:00:53
keggok2026-11-20 10:00:55
pubchemok2026-11-20 10:00:53
redditmissing (no r/tripreports posts mention it)2026-11-20 10:00:53
sidermissing (not in SIDER)2026-11-20 10:00:53
structureok2026-11-20 10:00:53
wikipediaok2026-11-20 10:00:53